Adults who have been diagnosed with attention deficit hyperactivity disorder (ADHD) may be living shorter lives than they should, finds a world-first study led by UCL researchers.
Faron details clinical plans for MDS drug; Cara to seek ‘strategic’ options
Plus, news about CSL Vifor, Akebia and Pan Cancer T: Faron gets FDA go-ahead for streamlined registrational path: The company said the regulator “acknowledged the